Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes

Neurobiology of Aging

Volumn 27, Issue 1, 2006, Pages 1-9

  Strekalova, Helen ^a   Buhmann, Carsten ^a   Kleene, Ralf ^a   Eggers, Christian ^a   Saffell, Jane ^b   Hemperly, John ^c   Weiller, Cornelius ^a   Müller Thomsen, Tomas ^a   Schachner, Melitta ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c BD Technologies   (United States)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Dementia; L1; NCAM

Indexed keywords

NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE L1;

ADULT; AGED; ALZHEIMER DISEASE; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 27744497956     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.11.013     Document Type: Article

References (52)

1. N. Andreasen, L. Minthon, P. Davidsson, E. Vanmechelen, H. Vanderstichele, and B. Winblad Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice Arch Neurol 58 2001 373 379
2. D. Barbeau, J.J. Liang, Y. Robitalille, R. Quirion, and L.K. Srivastava Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains Proc Natl Acad Sci USA 92 1995 2785 2789
3. B.R. Brooks, R.G. Miller, M. Swash, and T.L. Munsat El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis Amyotroph Lateral Scler Other Motor Neuron Disord 1 2000 293 299
4. O. Bukalo, M. Schachner, and A. Dityatev Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus Neuroscience 104 2001 359 369
5. C.W. Cotman, N.P. Hailer, K.K. Pfister, I. Soltesz, and M. Schachner Cell adhesion molecules in neural plasticity and pathology: similar mechanisms, distinct organizations? Prog Neurobiol 55 1998 659 669
6. H. Cremer, G. Chazal, A. Carleton, C. Goridis, J.D. Vincent, and P.M. Lledo Long-term but not short-term plasticity at mossy fiber synapses is impaired in neural cell adhesion molecule-deficient mice Proc Natl Acad Sci USA 95 1998 13242 13247
7. B.A. Cunningham, J.J. Hemperly, B.A. Murray, E.A. Prediger, R. Brackenbury, and G.M. Edelman Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing Science 236 1987 799 806
8. P.M. Dey, R.D. Graff, L.A. Lagunowich, and K.R. Reuhl Selective loss of the 180-kDa form of the neural cell adhesion molecule in hippocampus and cerebellum of the adult mouse following trimethyltin administration Toxicol Appl Pharmacol 126 1994 69 74
9. M. Eckhardt, O. Bukalo, G. Chazal, L. Wang, C. Goridis, and M. Schachner Mice deficient in the polysialyltransferase ST8SiaIV/PST-1 allow discrimination of the roles of neural cell adhesion molecule protein and polysialic acid in neural development and synaptic plasticity J Neurosci 2000 5234 5244
10. A. Faissner, D.B. Teplow, D. Kubler, G. Keilhauer, V. Kinzel, and M. Schachner Biosynthesis and membrane topography of the neural cell adhesion molecule L1 EMBO J 4 1985 3105 3113
11. R.D. Fields, and K. Itoh Neural cell adhesion molecules in activity-dependent development and synaptic plasticity Trends Neurosci 19 1996 473 480
12. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
13. E. Fransen, V. Lemmon, G. Van Camp, L. Vits, P. Coucke, and P.J. Willems CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1 Eur J Hum Genet 3 1995 273 284
14. M. Frosch, I. Gorgen, G.J. Boulnois, K.N. Timmis, and D. Bitter-Suermann NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci Proc Natl Acad Sci USA 82 1985 1194 1198
15. D. Galasko Cerebrospinal fluid opens a window on Alzheimer disease Arch Neurol 56 1999 655 656
16. A. Garlind, A. Brauner, B. Hojeberg, H. Basun, and M. Schultzberg Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients Brain Res 826 1999 112 116
17. W.R. Gibb, and A.J. Lees The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J Neurol Neurosurg Psychiatry 51 1988 745 752
18. S. Gilman, P.A. Low, N. Quinn, A. Albanese, Y. Ben Shlomo, and C.J. Fowler Consensus statement on the diagnosis of multiple system atrophy J Neurol Sci 163 1999 94 98
19. J.H. Growdon Biomarkers of Alzheimer disease Arch Neurol 56 1999 281 283
20. H. Hampel, K. Buerger, R. Kohnken, S.J. Teipel, R. Zinkowski, and H.J. Moeller Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231 Ann Neurol 49 2001 545 546
21. E. Harlow, and D. Lane Antibodies: a laboratory manual 1998 Cold Spring Harbor Laboratory Publications New York
22. J. Haspel, D.R. Friedlander, N. Ivgy-May, S. Chickramane, C. Roonprapunt, and S. Chen Critical and optimal Ig domains for promotion of neurite outgrowth by L1/Ng-CAM J Neurobiol 42 2000 287 302
23. C. Hock, K. Heese, F. Muller-Spahn, P. Huber, W. Riesen, and R.M. Nitsch Increased CSF levels of nerve growth factor in patients with Alzheimer's disease Neurology 54 2000 2009 2011
24. M. Jouet, A. Rosenthal, G. Armstrong, J. MacFarlane, R. Stevenson, and J. Paterson X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene Nat Genet 7 1994 402 407
25. I. Kalus, B. Schnegelsberg, N.G. Seidah, R. Kleene, and M. Schachner The proprotein convertase PC5A and a metalloprotease are involved in the proteolytic processing of the neural adhesion molecule L1 J Biol Chem 278 2003 10381 10388
26. H. Kamiguchi, M.L. Hlavin, and V. Lemmon Role of L1 in neural development: what the knockouts tell us Mol Cell Neurosci 12 1998 48 55
27. L. Krog, M. Olsen, A.M. Dalseg, J. Roth, and E. Bock Characterization of soluble neural cell adhesion molecule in rat brain, CSF, and plasma J Neurochem 59 1992 838 847
28. S. Lammich, E. Kojro, R. Postina, S. Gilbert, R. Pfeiffer, and M. Jasionowski Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease Proc Natl Acad Sci USA 96 1999 3922 3927
29. J.W. Law, A.Y. Lee, M. Sun, A.G. Nikonenko, S.K. Chung, and A. Dityatev Decreased anxiety, altered place learning, and increased CA1 basal excitatory synaptic transmission in mice with conditional ablation of the neural cell adhesion molecule L1 J Neurosci 23 2003 10419 10432
30. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, and F.D. Lublin Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
31. I.G. McKeith Dementia with Lewy bodies Br J Psychiatry 80 2002 144 147
32. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
33. P.D. Miller, W.W. Chung, C.F. Lagenaur, and S.T. DeKosky Regional distribution of neural cell adhesion molecule (N-CAM) and L1 in human and rodent hippocampus J Comp Neurol 327 1993 341 349
34. M. Montag-Sallaz, M. Schachner, and D. Montag Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1 Mol Cell Biol 22 2002 7967 7981
35. S. Murase, and E.M. Schuman The role of cell adhesion molecules in synaptic plasticity and memory Curr Opin Cell Biol 11 1999 549 553
36. N. Nayeem, S. Silletti, X. Yang, V.P. Lemmon, R.A. Reisfeld, and W.B. Stallcup A potential role for the plasmin(ogen) system in the posttranslational cleavage of the neural cell adhesion molecule L1 J Cell Sci 112 1999 4739 4749
37. O. Nybroe, A.M. Dalseg, and E. Bock A developmental study of soluble L1 Int J Dev Neurosci 8 1990 273 281
38. M. Olsen, L. Krog, K. Edvardsen, L.T. Skovgaard, and E. Bock Intact transmembrane isoforms of the neural cell adhesion molecule are released from the plasma membrane Biochem J 295 1993 833 840
39. G.C. Owens, G.M. Edelman, and B.A. Cunningham Organization of the neural cell adhesion molecule (N-CAM) gene: alternative exon usage as the basis for different membrane-associated domains Proc Natl Acad Sci USA 84 1987 294 298
40. M. Poltorak, M.A. Frye, R. Wright, J.J. Hemperly, M.S. George, and P.J. Pazzaglia Increased neural cell adhesion molecule in the CSF of patients with mood disorder J Neurochem 66 1996 1532 1538
41. M. Poltorak, I. Khoja, J.J. Hemperly, J.R. Williams, R. el Mallakh, and W.J. Freed Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia Exp Neurol 131 1995 266 272
42. A.E. Purcell, M.M. Rocco, J.A. Lenhart, K. Hyder, A.W. Zimmerman, and J. Pevsner Assessment of neural cell adhesion molecule (NCAM) in autistic serum and postmortem brain J Autism Dev Disord 31 2001 183 194
43. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, and J.H. Garcia Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260
44. L.C. Ronn, V. Berezin, and E. Bock The neural cell adhesion molecule in synaptic plasticity and ageing Int J Dev Neurosci 18 2000 193 199
45. A. Rosenthal, M. Jouet, and S. Kenwrick Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X-linked hydrocephalus Nat Genet 2 1992 107 112
46. A.E. Runker, U. Bartsch, K.A. Nave, and M. Schachner The C264Y missense mutation in the extracellular domain of L1 impairs protein trafficking in vitro and in vivo J Neurosci 23 2003 277 286
47. K. Sadoul, R. Sadoul, A. Faissner, and M. Schachner Biochemical characterization of different molecular forms of the neural cell adhesion molecule L1 J Neurochem 50 1988 510 521
48. M. Schachner Neural recognition molecules and synaptic plasticity Curr Opin Cell Biol 9 1997 627 634
49. J. Thelin, A. Waldenstrom, U. Bartsch, M. Schachner, and J. Schouenborg Heat nociception is severely reduced in a mutant mouse deficient for the L1 adhesion molecule Brain Res 965 2003 75 82
50. D. Thomaidou, D. Coquillat, S. Meintanis, M. Noda, G. Rougon, and R. Matsas Soluble forms of NCAM and F3 neuronal cell adhesion molecules promote Schwann cell migration: identification of protein tyrosine phosphatases zeta/beta as the putative F3 receptors on Schwann cells J Neurochem 78 2001 767 778
51. H.V. Wheal, Y. Chen, J. Mitchell, M. Schachner, W. Maerz, and H. Wieland Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity Prog Neurobiol 55 1998 611 640
52. E.J. Williams, P. Doherty, G. Turner, R.A. Reid, J.J. Hemperly, and F.S. Walsh Calcium influx into neurons can solely account for cell contact-dependent neurite outgrowth stimulated by transfected L1 J Cell Biol 119 1992 883 892